IBC’s Assay Development Conference has become a premier drug discovery event with an emphasis on robust and effective HTS assay development and the application of new screening technologies to reduce costs and accelerate discovery. The event addresses the most pressing challenges and critical issues that are faced by scientists in HTS laboratories including the design of cell-based assays, assay miniaturization, and implementation of state-of-the-art technologies. A key part of the conference is the Case Study Session where scientists from major pharmaceutical laboratories present real data from real screening assays.